Ipratropium/salbutamol

From Wikipedia, the free encyclopedia

Ipratropium/salbutamol
Combination of
Ipratropium	Muscarinic antagonist
Salbutamol	Short-acting β2-adrenergic agonist
Identifiers
CAS number	?
ATC code	?
PubChem	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	Inhalation

The combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.

Since it contains a CFC based propellant, it is being phased out in European Union countries.

v • d • e Drugs for obstructive airway diseases: asthma/COPD (R03) Adrenergics, inhalants Short acting β2-agonists: Salbutamol/Levosalbutamol • Fenoterol • Terbutaline • Pirbuterol • Procaterol • Bitolterol • Rimiterol • Carbuterol • Tulobuterol • Reproterol Long acting β2-agonists (LABA): Arformoterol • Bambuterol • Clenbuterol • Formoterol • Salmeterol Ultra LABA: Indacaterol other: Epinephrine • Isoprenaline (Isoproterenol) • Orciprenaline (Metaproterenol) Glucocorticoids Beclometasone • Budesonide • Ciclesonide • Fluticasone • Mometasone Anticholinergics Ipratropium • Tiotropium Mast cell stabilizers Cromoglicate • Nedocromil Xanthines Aminophylline • Theobromine • Theophylline Leukotriene antagonists Montelukast • Pranlukast • Zafirlukast Lipoxygenase inhibitor Zileuton Combination products Budesonide/formoterol • Fluticasone/salmeterol • Ipratropium/salbutamol